News headlines about HCA Holdings (NYSE:HCA) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. HCA Holdings earned a news sentiment score of 0.22 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.5476763244115 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the news stories that may have impacted Accern’s analysis:

Several analysts have issued reports on the stock. Zacks Investment Research lowered shares of HCA Holdings from a “buy” rating to a “hold” rating in a research report on Friday, July 14th. BidaskClub lowered shares of HCA Holdings from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Morgan Stanley reaffirmed an “equal weight” rating and set a $88.00 price target (down from $90.00) on shares of HCA Holdings in a research report on Wednesday, July 26th. Bank of America Corporation lowered shares of HCA Holdings from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $102.00 to $92.00 in a research report on Wednesday, July 26th. Finally, Citigroup Inc. dropped their price target on shares of HCA Holdings from $89.00 to $87.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.25.

Shares of HCA Holdings (HCA) opened at 76.18 on Tuesday. The firm has a market capitalization of $27.52 billion, a P/E ratio of 10.21 and a beta of 0.62. HCA Holdings has a 52 week low of $67.00 and a 52 week high of $91.03. The firm’s 50-day moving average is $77.75 and its 200-day moving average is $81.36.

In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total transaction of $171,742.00. Following the sale, the insider now directly owns 12,363 shares in the company, valued at $987,556.44. The sale was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders have sold 6,450 shares of company stock worth $511,163. Company insiders own 2.90% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This report was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://theolympiareport.com/2017/10/31/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-hca-holdings-hca-stock-price.html.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Insider Buying and Selling by Quarter for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.